The C-terminal region of lymphocytic choriomeningitis virus nucleoprotein contains distinct and segregable functional domains involved in NP-Z interaction and counteraction of the type I interferon response

Journal of Virology

Volumn 85, Issue 24, 2011, Pages 13038-13048

  Ortiz Riaño, Emilio ^a   Cheng, Benson Yee Hin ^a   de la Torre, Juan Carlos ^b   Martínez Sobrido, Luis ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; RING FINGER PROTEIN; VIRUS NUCLEOPROTEIN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RESPONSE; EMBRYO; GENETIC REASSORTMENT; HUMAN; HUMAN CELL; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS;

AMINO ACID SUBSTITUTION; ANIMALS; CARRIER PROTEINS; CELL LINE; INTERFERON TYPE I; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; NUCLEOPROTEINS; POINT MUTATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; VIRUS ASSEMBLY;

ARENAVIRUS; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

EID: 84855841164     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05834-11     Document Type: Article

References (65)

1. Barton, L. L. 1996. Lymphocytic choriomeningitis virus: a neglected central nervous system pathogen. Clin. Infect. Dis. 22:197.
2. Battegay, M., et al. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods 33:191-198.
3. Borden, K. L., E. J. Campbell Dwyer, and M. S. Salvato. 1998. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J. Virol. 72:758-766.
4. Borio, L., et al. 2002. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 287:2391-2405.
5. Borrow, P., L. Martinez-Sobrido, and J. C. de la Torre. 2010. Inhibition of the type I interferon antiviral response during arenavirus infection. Viruses 2:2443-2480.
6. Borrow, P., and M. B. Oldstone. 1994. Mechanism of lymphocytic choriomeningitis virus entry into cells. Virology 198:1-9.
7. Briese, T., et al. 2009. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog. 5:e1000455.
8. Buchmeier, M. J., J. C. de la Torre, and C. J. Peters. 2007. Arenaviridae: the viruses and their replication, p. 1791-1827. In P. D. Knipe et al. (ed.), Fields virology, 5th ed., vol. II. Lippincott Williams & Wilkins, Philadelphia, PA.
9. Campbell Dwyer, E. J., H. Lai, R. C. MacDonald, M. S. Salvato, and K. L. Borden. 2000. The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner. J. Virol. 74:3293-3300.
10. Charrel, R. N., and X. de Lamballerie. 2003. Arenaviruses other than Lassa virus. Antiviral Res. 57:89-100.
11. Clegg, J. C., and G. Lloyd. 1983. Structural and cell-associated proteins of Lassa virus. J. Gen. Virol. 64:1127-1136.
12. Cornu, T. I., and J. C. de la Torre. 2002. Characterization of the arenavirus RING finger Z protein regions required for Z-mediated inhibition of viral RNA synthesis. J. Virol. 76:6678-6688.
13. Cornu, T. I., and J. C. de la Torre. 2001. RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome. J. Virol. 75:9415-9426.
14. Cornu, T. I., H. Feldmann, and J. C. de la Torre. 2004. Cells expressing the RING finger Z protein are resistant to arenavirus infection. J. Virol. 78:2979-2983.
15. Eichler, R., et al. 2004. Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res. 100:249-255.
16. Fan, L., T. Briese, and W. I. Lipkin. 2010. Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction. J. Virol. 84:1785-1791.
17. Fischer, S. A., et al. 2006. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N. Engl. J. Med. 354:2235-2249.
18. Garcin, D., S. Rochat, and D. Kolakofsky. 1993. The Tacaribe arenavirus small zinc finger protein is required for both mRNA synthesis and genome replication. J. Virol. 67:807-812.
19. Groseth, A., et al. 2011. Tacaribe virus but not Junin virus infection induces cytokine release from primary human monocytes and macrophages. PLoS Negl. Trop. Dis. 5:e1137.
20. Groseth, A., S. Wolff, T. Strecker, T. Hoenen, and S. Becker. 2010. Efficient budding of the Tacaribe virus matrix protein Z requires the nucleoprotein. J. Virol. 84:3603-3611.
21. Gunther, S., and O. Lenz. 2004. Lassa virus. Crit. Rev. Clin. Lab. Sci. 41:339-390.
22. Harnish, D. G., W. C. Leung, and W. E. Rawls. 1981. Characterization of polypeptides immunoprecipitable from Pichinde virus-infected BHK-21 cells. J. Virol. 38:840-848.
23. Harrison, L. H., et al. 1999. Clinical case definitions for Argentine hemorrhagic fever. Clin. Infect. Dis. 28:1091-1094.
24. Harrison, M. S., T. Sakaguchi, and A. P. Schmitt. 2010. Paramyxovirus assembly and budding: building particles that transmit infections. Int. J. Biochem. Cell Biol. 42:1416-1429.
25. Hastie, K. M., C. R. Kimberlin, M. A. Zandonatti, I. J. MacRae, and E. O. Saphire. 2011. Structure of the Lassa virus nucleoprotein reveals a dsRNAspecific 3_ to 5_ exonuclease activity essential for immune suppression. Proc. Natl. Acad. Sci. U. S. A. 108:2396-2401.
26. Holmes, G. P., et al. 1990. Lassa fever in the United States. Investigation of a case and new guidelines for management. N. Engl. J. Med. 323:1120-1123.
27. Hu, C. D., and T. K. Kerppola. 2003. Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis. Nat. Biotechnol. 21:539-545.
28. Isaacson, M. 2001. Viral hemorrhagic fever hazards for travelers in Africa. Clin. Infect. Dis. 33:1707-1712.
29. Jacamo, R., N. Lopez, M. Wilda, and M. T. Franze-Fernandez. 2003. Tacaribe virus Z protein interacts with the L polymerase protein to inhibit viral RNA synthesis. J. Virol. 77:10383-10393.
30. Jahrling, P. B., and C. J. Peters. 1992. Lymphocytic choriomeningitis virus. A neglected pathogen of man. Arch. Pathol. Lab. Med. 116:486-488.
31. Kilgore, P. E., et al. 1997. Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin. Infect. Dis. 24:718-722.
32. Lee, K. J., I. S. Novella, M. N. Teng, M. B. Oldstone, and J. C. de La Torre. 2000. NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J. Virol. 74:3470-3477.
33. Lee, K. J., M. Perez, D. D. Pinschewer, and J. C. de la Torre. 2002. Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV like particles. J. Virol. 76:6393-6397.
34. Levingston Macleod, J. M., et al. 2011. Identification of two functional domains within the arenavirus nucleoprotein. J. Virol. 85:2012-2023.
35. Lopez, N., R. Jacamo, and M. T. Franze-Fernandez. 2001. Transcription and RNA replication of Tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor of these processes. J. Virol. 75:12241-12251.
36. Lukashevich, I. S. 1992. Generation of reassortants between African arenaviruses. Virology 188:600-605.
37. Lukashevich, I. S., et al. 1999. Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-alpha gene expression. J. Med. Virol. 59:552-560.
38. Martinez-Sobrido, L., et al. 2009. Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 83:11330-11340.
39. Martinez-Sobrido, L., P. Giannakas, B. Cubitt, A. Garcia-Sastre, and J. C. de la Torre. 2007. Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J. Virol. 81:12696-12703.
40. Martínez-Sobrido, L., E. I. Zúñiga, D. Rosario, A. García-Sastre, and J. C. de la Torre. 2006. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 80:9192-9199.
41. McCormick, J. B., and S. P. Fisher-Hoch. 2002. Lassa fever. Curr. Top. Microbiol. Immunol. 262:75-109.
42. McCormick, J. B., et al. 1986. Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med. 314:20-26.
43. McKee, K. T., Jr., J. W. Huggins, C. J. Trahan, and B. G. Mahlandt. 1988. Ribavirin prophylaxis and therapy for experimental Argentine hemorrhagic fever. Antimicrob. Agents Chemother. 32:1304-1309.
44. Mets, M. B., L. L. Barton, A. S. Khan, and T. G. Ksiazek. 2000. Lymphocytic choriomeningitis virus: an underdiagnosed cause of congenital chorioretinitis. Am. J. Ophthalmol. 130:209-215.
45. Munoz-Jordan, J. L., et al. 2005. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J. Virol. 79:8004-8013.
46. Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for highexpression transfectants with a novel eukaryotic vector. Gene 108:193-199.
47. Ortiz-Riaño, E., B. Cheng, J. C. de la Torre, and L. Martinez-Sobrido. Self-association of lymphocytic choriomeningitis virus nucleoprotein is mediated by its N-terminal region and is not required for its anti-interferon function. J. Virol., in press.
48. Palacios, G., et al. 2008. A new arenavirus in a cluster of fatal transplantassociated diseases. N. Engl. J. Med. 358:991-998.
49. Pannetier, D., C. Faure, M. C. Georges-Courbot, V. Deubel, and S. Baize. 2004. Human macrophages, but not dendritic cells, are activated and produce alpha/beta interferons in response to Mopeia virus infection. J. Virol. 78:10516-10524.
50. Perez, M., R. C. Craven, and J. C. de la Torre. 2003. The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc. Natl. Acad. Sci. U. S. A. 100:12978-12983.
51. Perez, M., D. L. Greenwald, and J. C. de la Torre. 2004. Myristoylation of the RING finger Z protein is essential for arenavirus budding. J. Virol. 78:11443-11448.
52. Peters, C. J. 2002. Human infection with arenaviruses in the Americas. Curr. Top. Microbiol. Immunol. 262:65-74.
53. Pinschewer, D. D., M. Perez, and J. C. de la Torre. 2003. Role of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication. J. Virol. 77:3882-3887.
54. Qi, X., et al. 2010. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 468:779-783.
55. Rodrigo, W. W., J. C. de la Torre, and L. Martinez-Sobrido. 2011. Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses. J. Virol. 85:1684-1695.
56. Rodriguez, M., J. B. McCormick, and M. C. Weissenbacher. 1986. Antiviral effect of ribavirin on Junin virus replication in vitro. Rev. Argent. Microbiol. 18:69-74.
57. Rossman, J. S., and R. A. Lamb. 2011. Influenza virus assembly and budding. Virology 411:229-236.
58. Schmitt, A. P., and R. A. Lamb. 2004. Escaping from the cell: assembly and budding of negative-strand RNA viruses. Curr. Top. Microbiol. Immunol. 283:145-196.
59. Shtanko, O., et al. 2010. A role for the C terminus of Mopeia virus nucleoprotein in its incorporation into Z protein-induced virus-like particles. J. Virol. 84:5415-5422.
60. Snell, N. 1988. Ribavirin therapy for Lassa fever. Practitioner 232:432.
61. Strecker, T., et al. 2003. Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J. Virol. 77:10700-10705.
62. Strecker, T., et al. 2006. The role of myristoylation in the membrane association of the Lassa virus matrix protein Z. Virol. J. 3:93.
63. Urata, S., J. Yasuda, and J. C. de la Torre. 2009. The Z protein of the New World arenavirus Tacaribe virus has bona fide budding activity that does not depend on known late domain motifs. J. Virol. 83:12651-12655.
64. Weissenbacher, M. C., R. P. Laguens, and C. E. Coto. 1987. Argentine hemorrhagic fever. Curr. Top. Microbiol. Immunol. 134:79-116.
65. Wilda, M., N. Lopez, J. C. Casabona, and M. T. Franze-Fernandez. 2008. Mapping of the Tacaribe arenavirus Z-protein binding sites on the L protein identified both amino acids within the putative polymerase domain and a region at the N terminus of L that are critically involved in binding. J. Virol. 82:11454-11460.